Gentex (GNTX) Cash & Equivalents (2009 - 2026)

Gentex (GNTX) has 18 years of Cash & Equivalents data on file, last reported at $164.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 42.5% year-over-year to $164.8 million; the trailing twelve-month figure through Mar 2026 stood at $164.8 million (down 42.5% YoY), and the FY2025 full-year result was $145.6 million, down 37.58% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $164.8 million, up from $145.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $286.6 million in Q1 2025 and bottomed at $119.8 million in Q2 2025.
• The 5-year median for Cash & Equivalents is $226.4 million (2023), against an average of $220.3 million.
• The widest annual swing landed in 2023, when Cash & Equivalents gained 16.91%; it then tumbled 53.98% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $214.8 million in 2022, then grew by 5.44% to $226.4 million in 2023, then climbed by 3.04% to $233.3 million in 2024, then sank by 37.58% to $145.6 million in 2025, then increased by 13.12% to $164.8 million in 2026.
• The last three Cash & Equivalents figures came in at $164.8 million (Q1 2026), $145.6 million (Q4 2025), and $178.6 million (Q3 2025), per Business Quant data.

Peer Comparison